Inceptiv™ neurostimulator
Rechargeable spinal cord stimulator
with sensing technology
Inceptiv™ is the most advanced SCS system with closed-loop technology1-3 for chronic pain relief.
Download brochure
Overview
Relief in tune with pain
Inceptiv™ Spinal Cord Stimulator
Discover why Inceptiv™ is the most advanced SCS system with closed-loop technology
Need for consistent therapy
Fixed-output systems do not account for shifts in lead-to-spinal cord distance, which may result in inconsistent therapy dose4 and can compromise patient experience.
With fixed-output systems, patients need to make adjustments to deliver optimal therapy, regardless of waveform. Under- and overdosing can lead to variable therapy experience.
Variability in electrode distance to spinal cord due to activities and position
Inceptiv™ SCS listens and responds
Inceptiv™ SCS system with closed loop technology senses* neutral response and automatically adjusts stimulation to maintain therapy level during all patients activities.
Automatic:
does not depend on adjustments from the patient to maintain stimulation
Responsive:
instantly adjusts therapy delivery in real time
Seamless:
provides consistent therapy while patients perform a full range of daily activities
Inceptiv™ actively listens*5 to the spinal cord and responds instantly.
Superior back pain relief †, personalised
The Inceptiv™ system delivers DTM™ SCS therapy, now optimized moment-to-moment
Closed-loop SCS offers flexibility of therapy programming, based on patient preference.
highest back pain responder rate reported at 12 months in similar RCTs‡ (≥50% improvement)1.
of DTM™ SCS patients were profound back pain responders (≥80% pain relief).1
*
Sensing signals may not be measurable in all cases.
†
DTM™ SCS superior outcomes demonstrated using open-loop SCS therapy.
‡
Descriptive comparison, including studies with similar design (RCT; randomization >100 subjects; comparing 2 SCS therapies; with at least 12-months follow-up) and patient populations (inclusion/exclusion criteria; baseline demographics) with back pain responder rates reported. This is not based on a statistical analysis of outcomes between studies.
Your Inceptiv™ SCS patients can now enjoy greater freedom.
More consistent therapy, more time for life
Best full-body MRI access
The first and only full-body 1.5T and 3T MRI SCS system§
82%
of patients are expected to need an
MRI within 5 years post implant6
90%
access to MRI scanners7§
Inceptiv™ offers the most access to life-changing diagnostic imaging§
Inceptiv™ advantage with SureScan™ portfolio
✔ Able to scan high impedance or fractured lead
✔ Able to scan fully discharged device
✔ 1.5T and 3T MR conditional whole body normal operating mode
✔ Able to scan patient in prone position, e.g., breast MRI
§ 8 Under specific conditions. Refer to product labeling for full list of conditions.
Continue reading about Inceptiv™
Download the brochure for more information on the game changer in chronic pain therapy — the Inceptiv™ system.
Learn more about Inceptiv™
Are you interested in receiving additional information from a Medtronic representative about the Inceptiv™ device?
Read about
DTM™ SCS
Click to learn more about DTM™ SCS, a proprietary waveform supported by pre-clinical research and clinical research delivering Superior Pain Relief. Proven1.
1
Fishman M, Cordner H, Justiz R, et al. 12-Month Results from Multicenter, Open-Label, Randomized Controlled Clinical Trial Comparing Differential Target Multiplexed Spinal Cord Stimulation and Traditional Spinal Cord Stimulation in Subjects with Chronic Intractable Back Pain and Leg Pain. Pain Pract. 2021; 21: 912– 923. doi:10.1111/papr.13066
2
Inceptiv IFU with MRI labeling. 2023. M010773C001 Rev B. M009826C001 Rev B. M939858A028 Rev A.
3
Evoke SCS System User Manual. 2022 Saluda Medical. CLINUMAN-002426 Revision: 16.00.
4
ECHO MAC Final Clinical Study Report V1.0 2021-08-18
5
Vallejo R, Chakravarthy K, Will A, Trutnau K, Dinsmoor D. A new direction for closed-loop spinal cord stimulation: combining contemporary therapy paradigms with evoked compound action potential sensing. J Pain Res. 2021;14:3909-3918. doi 10.2147/JPR. S344568.
6
Desai MJ, Hargens LM, Breitenfeldt MD, et al. The rate of magnetic resonance imaging in patients with spinal cord stimulation. Spine. 2015;40(9):E531-537
7
Diagnostic Imaging Equipment Servicing. Market Insights. Western Europe: Clarivate; 2022. Report No. 47031053
See the device manual for detailed information regarding the instructions for use, indications, contraindications, warnings, precautions, and potential adverse events. If using an MRI SureScan® device, see the MRI SureScan® technical manual before performing an MRI. For further information, contact your local Medtronic representative and/or consult the Medtronic website at medtronic.eu.
For applicable products, consult instructions for use on www.medtronic.com/manuals. Manuals can be viewed using a current version of any major internet browser. For best results, use Adobe Acrobat® Reader with the browser.